Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03843463 · ClinicalTrials.gov registry record · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
A Phase 2 study of Stroke and Aphasia, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
- 3
- Study locations
NCT03843463 is a Phase 2 study of Stroke and Aphasia that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 88 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT03843463, a Phase 2 study of Stroke and Aphasia, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
- 3
- Study locations
Study Summary
In this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by naming untrained pictures and describing pictures, in individuals with aphasia in the acute and subacute post stroke period (i.e., within three months post stroke).
Interventions
- DRUG Placebo
- DRUG Escitalopram 10mg
- BEHAVIORAL Computer-delivered naming treatment
Study Locations (3)
South Carolina
- Medical University of South Carolina - Charleston
- University of South Carolina - Columbia
Maryland
- Johns Hopkins School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2021-07-18 |
| Est. Completion | 2027-01-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03843463
The ClinicalTrials.gov registry entry for NCT03843463 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03843463 reports 3 study locations spanning 2 distinct geographic areas - top geographies include South Carolina, Maryland.
Frequently Asked Questions
What is clinical trial NCT03843463 about?
NCT03843463 is a clinical study titled "Escitalopram and Language Intervention for Subacute Aphasia". In this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by naming untrained pictures and describing pictures, in individuals with aphasia in the acute and subacute post...
What is the current status of trial NCT03843463?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2021-07-18. Estimated completion is 2027-01-18.
What conditions does trial NCT03843463 study?
This clinical trial studies the following conditions: Stroke, Aphasia.
What interventions are being tested in trial NCT03843463?
The interventions under investigation include: Placebo (DRUG), Escitalopram 10mg (DRUG), Computer-delivered naming treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03843463?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03843463 being conducted?
This trial has 3 study locations across Maryland, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
RECRUITING · Phase 2
-
Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia
RECRUITING · Phase 2
-
Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia
RECRUITING · Phase 2
-
Myofascial Dysfunction in Post Stroke Shoulder Pain
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.